ProfileGDS4718 / 1560220_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 13% 21% 16% 11% 9% 14% 14% 12% 14% 10% 17% 14% 20% 11% 11% 17% 14% 12% 7% 12% 15% 18% 15% 13% 15% 10% 11% 10% 20% 18% 13% 13% 12% 13% 7% 11% 11% 18% 15% 17% 15% 11% 11% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9552415
GSM549102patient 115, normal, homogenized [OPG study]3.9039513
GSM549104patient 119, normal, homogenized [OPG study]4.1565521
GSM549108patient 138, normal, homogenized [OPG study]4.0428516
GSM549119patient 077, normal, homogenized [OPG study]3.8240411
GSM549133patient 032, cancer, homogenized [OPG study]3.700829
GSM549139patient 042, cancer, homogenized [OPG study]3.9081814
GSM549099patient 107, normal, homogenized [OPG study]3.9313714
GSM549109patient 139, normal, homogenized [OPG study]3.8747212
GSM549110patient 046, normal, homogenized [OPG study]3.9386714
GSM549114patient 063, normal, homogenized [OPG study]3.7682610
GSM549122patient 082, normal, homogenized [OPG study]4.0418717
GSM549134patient 033, cancer, homogenized [OPG study]3.9216214
GSM549136patient 036, cancer, homogenized [OPG study]4.08420
GSM549140patient 044, cancer, homogenized [OPG study]3.7768211
GSM549111patient 047, normal, homogenized [OPG study]3.7795411
GSM549113patient 057, normal, homogenized [OPG study]3.9989417
GSM549132patient 031, cancer, homogenized [OPG study]3.9266714
GSM549137patient 038, cancer, homogenized [OPG study]3.840912
GSM549142patient 047, cancer, homogenized [OPG study]3.713227
GSM549100patient 110, normal, homogenized [OPG study]3.8696812
GSM549107patient 135, normal, homogenized [OPG study]3.9288215
GSM549115patient 068, normal, homogenized [OPG study]4.0386918
GSM549116patient 072, normal, homogenized [OPG study]3.9476615
GSM549120patient 078, normal, homogenized [OPG study]3.8681913
GSM549131patient 030, cancer, homogenized [OPG study]3.9278115
GSM549118patient 074, normal, homogenized [OPG study]3.8016510
GSM549129patient 027, cancer, homogenized [OPG study]3.8286811
GSM549123patient 088, normal, homogenized [OPG study]3.7992910
GSM549124patient 006, cancer, homogenized [OPG study]4.178720
GSM549126patient 015, cancer, homogenized [OPG study]4.0440418
GSM549128patient 025, cancer, homogenized [OPG study]3.879413
GSM549103patient 117, normal, homogenized [OPG study]3.9023113
GSM549117patient 073, normal, homogenized [OPG study]3.8669212
GSM549138patient 041, cancer, homogenized [OPG study]3.8861113
GSM549141patient 045, cancer, homogenized [OPG study]3.626817
GSM549130patient 028, cancer, homogenized [OPG study]3.8106811
GSM549101patient 111, normal, homogenized [OPG study]3.830411
GSM549105patient 128, normal, homogenized [OPG study]4.0684218
GSM549106patient 134, normal, homogenized [OPG study]3.9115115
GSM549112patient 048, normal, homogenized [OPG study]4.0286517
GSM549125patient 011, cancer, homogenized [OPG study]3.9895115
GSM549127patient 024, cancer, homogenized [OPG study]3.7779711
GSM549135patient 035, cancer, homogenized [OPG study]3.7823811